Trafalgar International (GCAN) Cash & Equivalents (2017 - 2026)
Trafalgar International (GCAN) posted Cash & Equivalents of $1439.0 for Q1 2026, up 76.56% on a QoQ basis from $815.0 in Q4 2025, and down 96.89% year-over-year from $46213.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Cash & Equivalents (2017 - 2026) Analysis & Trends
Trafalgar International has reported Cash & Equivalents for 10 years, with the latest figure at $1439.0 in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 96.89% year-over-year to $1439.0 in Q1 2026; TTM through Mar 2026 was $1439.0, a 96.89% decrease from a year earlier, with the FY2025 full-year figure at $815.0, down 98.58% from the prior year.
- Cash & Equivalents was $1439.0 for Q1 2026 at Trafalgar International, up from $815.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $367589.0 in Q1 2022, with the low at $815.0 in Q4 2025.
- Average Cash & Equivalents over 5 years is $148377.9, with a median of $129323.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Cash & Equivalents grew 16.06% in 2022, then slumped 98.58% in 2025.
- Over 5 years, Cash & Equivalents stood at $270030.0 in 2022, then tumbled by 38.21% to $166859.0 in 2023, then slumped by 65.62% to $57368.0 in 2024, then plunged by 98.58% to $815.0 in 2025, then soared by 76.56% to $1439.0 in 2026.
- The last three Cash & Equivalents figures came in at $1439.0 (Q1 2026), $815.0 (Q4 2025), and $21355.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 976.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 7.38 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 815.44 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 3.98 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 1.80 Bn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 1,439.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,439.00 |
| Dec 31, 2025 | 815.00 |
| Sep 30, 2025 | 21,355.00 |
| Jun 30, 2025 | 26,712.00 |
| Mar 31, 2025 | 46,213.00 |
| Dec 31, 2024 | 57,368.00 |
| Sep 30, 2024 | 62,282.00 |
| Jun 30, 2024 | 80,316.00 |
| Mar 31, 2024 | 129,323.00 |
| Dec 31, 2023 | 166,859.00 |
| Sep 30, 2023 | 199,532.00 |
| Jun 30, 2023 | 240,747.00 |
| Mar 31, 2023 | 251,553.00 |
| Dec 31, 2022 | 270,030.00 |
| Sep 30, 2022 | 289,094.00 |
| Jun 30, 2022 | 311,197.00 |
| Mar 31, 2022 | 367,589.00 |
| Dec 31, 2021 | 377,520.00 |
| Sep 30, 2021 | 456,358.00 |
| Jun 30, 2021 | 528,930.00 |